fibrinogen-targeting therapy (Therini Bio)

N/A

Report date: 2025/06/11 11:11:58
NME

Base Information

Drug Namefibrinogen-targeting therapy (Therini Bio)
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionFibrin clot formation pathway modulators
TargetsUpdating
Therapy Area/IndicationsDiabetic macular oedema
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTherini Bio Inc
China Registration ClassN/A

Develop Information

Active CompaniesTherini Bio Inc
Inactive CompaniesN/A
Active IndicationsDiabetic macular oedema
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A